Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis
Objectives 5-aminosalicylate (mesalazine; 5-ASA) is an established first-line treatment for mild-to-moderate ulcerative colitis (UC). This study aimed to model the benefits of optimising 5-ASA therapy.Methods A decision tree model followed 10 000 newly diagnosed patients with mild-to-moderately acti...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
2022-10-01
|
| Serier: | BMJ Open Gastroenterology |
| Online adgang: | https://bmjopengastro.bmj.com/content/9/1/e000853.full |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
